Urotensin II as a novel marker for portal hypertension and bleeding varices: an Egyptian survey

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Egyptian Liver Journal

• Publication date

  2015-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.ELX.0000475366.85685.4c
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathophysiology of Portal Hypertension

  2015cited by this paper
• P1257 UROTENSIN-II (U-II) IN CHILDREN WITH PRE-SINUSOIDAL PORTAL HYPERTENSION

  2014cited by this paper
• Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis.

  2011cited by this paper
• Urotensin II Levels Are an Important Marker for the Severity of Portal Hypertension in Children

  2011cited by this paper
• Role of urotensin II in health and disease.

  2010cited by this paper
• Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.

  2008cited by this paper
• Increased circulating urotensin II in cirrhosis: potential implications in liver disease.

  2008cited by this paper
• Molecular mechanisms of hepatic fibrogenesis

  2007cited by this paper
• Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.

  2005cited by this paper
• Plasma concentration of urotensin II is raised in hypertension

  2004cited by this paper
• Direct Actions of Urotensin II on the Heart: Implications for Cardiac Fibrosis and Hypertrophy

  2003cited by this paper
• Human urotensin-II as a novel cardiovascular target: 'heart' of the matter or simply a fishy 'tail'?

  2003cited by this paper
• Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension.

  2001cited by this paper
• Plasma endothelin-1 level as a marker reflecting the severity of portal hypertension in biliary atresia.

  2001cited by this paper
• Acute variceal bleeding: general management.

  2001cited by this paper
• Complications of cirrhosis. I. Portal hypertension.

  2000cited by this paper
• Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

  1999cited by this paper
• Clinical implications of the white nipple sign and its role in the diagnosis of esophageal variceal hemorrhage

  1996cited by this paper
• Clinical implications of the white nipple sign and its role in the diagnosis of esophageal variceal hemorrhage.

  1996cited by this paper
• [Relationships between plasma concentrations of endothelin and the severity of liver cirrhosis].

  1994cited by this paper
• Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices -- a prospective controlled randomized trial.

  1982cited by this paper
• Prophylactic Endoscopic Sclerosing Treatment of the Esophageal Wall in Varices - A Prospective Controlled Randomized Trial

  1982cited by this paper
• Transection of the oesophagus for bleeding oesophageal varices

  1973cited by this paper

• No citing papers are available for this paper.